Clearside Biomedical, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CLSD Nasdaq 2830 clearsidebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Clearside Biomedical, Inc.

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q3 Loss, Beats Revenue Estimates - Nov 10th, 2025 3:30 pm
AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Tops Revenue Estimates - Nov 6th, 2025 3:45 pm
How Recent Moves Are Rewriting the Story for Clearside Biomedical - Sep 17th, 2025 6:18 am
Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress - Aug 26th, 2025 6:05 am
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates - Aug 8th, 2025 3:30 pm
Compugen (CGEN) Reports Q2 Loss, Lags Revenue Estimates - Aug 6th, 2025 6:20 am
Top Midday Gainers - Jul 23rd, 2025 12:00 pm
BC-Most Active Stocks - Jul 23rd, 2025 8:30 am
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada - Jul 23rd, 2025 5:05 am
Sector Update: Health Care Stocks Softer Late Afternoon - Jul 18th, 2025 1:51 pm
Snowflake initiated, Chipotle upgraded: Wall Street's top analyst calls - Jul 18th, 2025 7:38 am
Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline - Jul 17th, 2025 5:05 am
Shareholders in Clearside Biomedical (NASDAQ:CLSD) are in the red if they invested five years ago - Jun 28th, 2025 7:56 am
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - Jun 17th, 2025 5:05 am
Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know - May 29th, 2025 10:00 am
Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum - May 21st, 2025 5:05 am
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates - May 14th, 2025 3:35 pm
Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update - May 14th, 2025 2:05 pm
Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting - May 9th, 2025 5:05 am
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - May 8th, 2025 5:05 am